Results 141 to 150 of about 1,311 (180)

Autologous hematopoietic stem cells transplantation in MOGAD

Multiple Sclerosis Journal
[no abstract available]
Mariotto, Sara, Carta, Sara
openaire   +3 more sources

Mobilization of Hematopoietic Stem Cells for Use in Autologous Transplantation

Clinical Journal of Oncology Nursing, 2010
Autologous hematopoietic stem cell transplantation (HSCT) is a potentially curative therapeutic approach for various malignant hematologic and lymphoid diseases. Hematopoietic stem cells (HSCs) may be collected from the blood or the bone marrow. HSCs are capable of self-renewal and give rise to progenitor cells, multipotent cells that differentiate and
Hollie, Devine, D Kathryn, Tierney, Kim, Schmit-Pokorny, Kathleen, McDermott   +3 more
openaire   +2 more sources

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis

Current Stem Cell Research & Therapy, 2011
Systemic sclerosis is a rare disorder manifesting as skin and internal organ fibrosis, a diffuse vasculopathy, inflammation, and features of autoimmunity. Patients with diffuse cutaneous disease or internal organ involvement have a poor prognosis with high mortality. To date no therapy has been shown to reverse the natural course of the disease. Immune
Francesca, Milanetti, Jurate, Bucha, Alessandro, Testori, Richard K, Burt   +3 more
openaire   +2 more sources

Autologous hematopoietic stem cell transplantation in autoimmune diseases

Expert Review of Hematology, 2009
The term 'autoimmune diseases' encompasses a spectrum of diseases whose clinical manifestations and, possibly, biological features vary widely. The results of conventional treatment are considered unsatisfactory in aggressive forms, with subsets of patients having short life expectancies.
C. Annaloro, F. Onida, G. Lambertenghi Deliliers   +2 more
openaire   +3 more sources

Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation

Journal of Clinical Apheresis, 2010
AbstractHigh‐dose chemotherapy with autologous stem cell transplantation (ASCT) is curative treatment in various hematologic malignancies. Mobilization and collection of peripheral blood stem cell is the essential part of ASCT. The aim of this study was to evaluate the effectiveness of various mobilization regimens, determine the risk factors ...
YEGİN, ZEYNEP ARZU, Aki, Sahika Zeynep, Acar, Kadir, Sucak, Gulsan Turkoz, Yagci, Munci, ÖZKURT, ZÜBEYDE NUR, Suyani, Elif   +6 more
openaire   +3 more sources

[Autologous hematopoietic stem cell transplantation].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2009
Currently, autologous hematopoietic stem cell (SCT) transplantation is frequently used as a method of treatment for various hematologic malignant neoplasms and some solid tumors in adults and children. Autologous stem cells can be obtained in most instances from the patient's bone marrow or peripheral blood.
openaire   +3 more sources

Autologous hematopoietic stem cell transplantation in multiple sclerosis

Neurology, 2017
To summarize the evidence on immunoablative therapy followed by autologous hematopoietic stem cell transplantation (aHSCT) to manage severe and treatment-refractory multiple sclerosis (MS).We collected all the published studies of aHSCT in any form of MS from 1995 to 2016, carefully excluding reports that were updated in subsequent studies.
Sormani, Maria Pia, Muraro, Paolo A., Schiavetti, Irene, Signori, Alessio, Laroni, Alice, Saccardi, Riccardo, Mancardi, Gian Luigi, Capello, E., Uccelli, A., Bagigalupo, F., Repice, A. M., Portaccio, E., Barillaro, A., Russo, C., De Luca, Giovanna, Farina, D., Tartaro, A., Blanco, Y., Berenguer, J., Bresciani, P., Cuoghi, A., Zonari, P.   +21 more
openaire   +3 more sources

Autologous hematopoietic stem cell transplantation for Crohn's disease

Autoimmunity Reviews, 2002
The feasibility and early experience of hematopoietic stem cell transplantation for severe Crohn's disease (CD) are discussed. The natural history, therapy, and evidence for autoimmunity of CD are outlined and related to this new therapy in terms of morbidity and mortality.
openaire   +2 more sources

Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma

Expert Opinion on Biological Therapy, 2015
High-dose chemotherapy and autologous stem cell transplantation (ASCT) improve survival in follicular lymphoma; however, relapse remains the most common cause of death. The lower risk of relapse with allogeneic SCT (alloSCT) is offset by a high transplant-related mortality (TRM).English articles indexed in the MEDLINE database were reviewed to discuss ...
V R, Bhatt, J O, Armitage
openaire   +2 more sources

Autologous hematopoietic stem cell transplantation for MS

Neurology, 2017
Multiple sclerosis (MS) is likely initiated by an autoimmune response that targets the CNS. A common conceptualization of the early stages of MS is that immunocompetent cells of the adaptive immune system, recognizing hitherto unknown autoantigens, invade the CNS.
Joachim, Burman, Robert J, Fox
openaire   +2 more sources